REN HENG PHARM LIMITED
As of 17 November 2026, for the company name REN HENG PHARM LIMITED as recorded, 8 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 33 records, across 21 drug names; since 21 August 2026, the records list Marketing application approved: 1 application, Accepted: 2 applications; the chemical-drug catalogue lists 1 active record with this name as holder; 1 active API registration lists this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/17.
Drug filings
33 acceptance records as first applicant, grouped into 21 source drug names. Source data as of 2026/11/17.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Polyvinyl Alcohol Eye Drops 4 records · Latest accepted 2026/11/09
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602753 | Generic | 2026/11/09 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
| CYHS2602752 | Generic | 2026/11/09 | REN HENG PHARM LIMITED; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2502212 | Generic | 2025/06/20 | REN HENG PHARM LIMITED; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2404210 | Generic | 2024/12/06 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
二甲双胍恩格列净片(I) · No verified English name 3 records · Latest accepted 2026/07/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601797 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2600622 | Generic | 2026/03/06 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2402168 | Generic | 2024/07/13 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
二甲双胍恩格列净片(V) · No verified English name 3 records · Latest accepted 2026/07/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601796 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2600620 | Generic | 2026/03/06 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2402167 | Generic | 2024/07/13 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
二甲双胍恩格列净片(VI) · No verified English name 3 records · Latest accepted 2026/07/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2601795 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2600619 | Generic | 2026/03/06 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2402166 | Generic | 2024/07/13 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Gatifloxacin Eye Drops 2 records · Latest accepted 2026/05/28
Supplement · 1Generic · 1
Calcitonin Salmon Injection 1 records · Latest accepted 2026/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600078 | Generic | 2026/01/08 | REN HENG PHARM LIMITED; Gansu Cheng Ji Bio Pharma Co., Ltd. romanized | CDE ↗ |
Cefditoren Pivoxil Granules 2 records · Latest accepted 2026/01/04
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504528 | Generic | 2026/01/04 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| CYHS2504527 | Generic | 2026/01/04 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Acetylcysteine Tablets 1 records · Latest accepted 2025/04/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501401 | Generic | 2025/04/11 | REN HENG PHARM LIMITED; Guangzhou Lv Shi Zi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Pheniramine Maleate Naphazoline Hydrochloride Eye Drops 1 records · Latest accepted 2024/11/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404097 | Generic | 2024/11/28 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
Pentoxifylline Modified Release Tablets 1 records · Latest accepted 2024/10/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403696 | Generic | 2024/10/31 | REN HENG PHARM LIMITED; Hunan Jiudian Pharmaceutical Co., Ltd | CDE ↗ |
维生素B??注射液 · No verified English name 1 records · Latest accepted 2024/10/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403517 | Generic | 2024/10/17 | REN HENG PHARM LIMITED; Lang Tian Pharma (Hubei) Co., Ltd. romanized | CDE ↗ |
Bromfenac Sodium Eye Drops 1 records · Latest accepted 2024/08/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402682 | Generic | 2024/08/17 | REN HENG PHARM LIMITED; Beijing Hui En Lan De Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Moxifloxacin Hydrochloride Eye Drops 2 records · Latest accepted 2024/07/27
Supplement · 1Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401125 | Supplement | 2024/07/27 | REN HENG PHARM LIMITED; Guangzhou Da Guang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2201299 | Generic | 2022/08/16 | REN HENG PHARM LIMITED; Guangzhou Da Guang Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Emedastine Difumarate Eye Drops 1 records · Latest accepted 2024/06/04
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401666 | Generic | 2024/06/04 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
Tobramycin Eye Drops 1 records · Latest accepted 2024/05/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401636 | Generic | 2024/05/31 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
Latanoprost Eye Drops 1 records · Latest accepted 2024/05/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401577 | Generic | 2024/05/27 | REN HENG PHARM LIMITED; Zhongshan Wanhan Pharmaceuticals Co., Ltd. | CDE ↗ |
Acetylcysteine Oral Solution 1 records · Latest accepted 2023/11/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303279 | Generic | 2023/11/28 | REN HENG PHARM LIMITED; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CDE ↗ |
维生素B12滴眼液 · No verified English name 1 records · Latest accepted 2023/11/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302984 | Generic | 2023/11/02 | REN HENG PHARM LIMITED; Guangdong Nan Guo Pharma Co., Ltd. romanized | CDE ↗ |
Epalrestat Tablets 1 records · Latest accepted 2023/08/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302333 | Generic | 2023/08/31 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2023/05/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301308 | Generic | 2023/05/13 | REN HENG PHARM LIMITED; Hunan Jiudian Pharmaceutical Co., Ltd | CDE ↗ |
Pranoprofen Eye Drops 1 records · Latest accepted 2023/03/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300907 | Generic | 2023/03/28 | REN HENG PHARM LIMITED; Hangzhou Minsheng Pharmaceutical Co., Ltd | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/21 to 2026/11/18. CDE data as of 2026/11/17; NMPA data as of 2026/11/17.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationAccepted: 2 applications
- 2026/11/09Accepted
Polyvinyl Alcohol Eye Drops
CYHS2602753
Fact date: 2026/11/09 · Date added to this site: 2026/11/10
View source ↗ - 2026/11/09Accepted
Polyvinyl Alcohol Eye Drops
CYHS2602752
Fact date: 2026/11/09 · Date added to this site: 2026/11/10
View source ↗ - 2026/11/03Marketing application approved
Acetylcysteine Tablets
CYHS2501401 · 国药准字H20266430
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Date added to this site: 2026/11/06
View source · Table row 50 ↗
Under review
8 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Polyvinyl Alcohol Eye Drops | CYHS2602753 | Generic | 2026/11/09 | REN HENG PHARM LIMITED; Hefei Hua Wei Pharma Co., Ltd. romanized | CDE ↗ |
| Polyvinyl Alcohol Eye Drops | CYHS2602752 | Generic | 2026/11/09 | REN HENG PHARM LIMITED; You Ni Te Er Nanjing Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 二甲双胍恩格列净片(I) · No verified English name | CYHS2601797 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| 二甲双胍恩格列净片(V) · No verified English name | CYHS2601796 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| 二甲双胍恩格列净片(VI) · No verified English name | CYHS2601795 | Generic | 2026/07/27 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| Calcitonin Salmon Injection | CYHS2600078 | Generic | 2026/01/08 | REN HENG PHARM LIMITED; Gansu Cheng Ji Bio Pharma Co., Ltd. romanized | CDE ↗ |
| Cefditoren Pivoxil Granules | CYHS2504528 | Generic | 2026/01/04 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
| Cefditoren Pivoxil Granules | CYHS2504527 | Generic | 2026/01/04 | REN HENG PHARM LIMITED; Suzhou Di San Pharmaceutical Factory Co., Ltd. romanized | CDE ↗ |
Catalogue holder records
1 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/17. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Pentoxifylline Modified Release Tablets | REN HENG PHARM LIMITED | Hunan Jiudian Pharmaceutical Co., Ltd | 国药准字H20264838 | 2026/06/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
1 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/17.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 奈帕芬胺 · No verified English name | REN HENG PHARM LIMITED | Y20180001632 | I | 2019/03/01 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
0 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/17.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/17
- Chemical-drug catalogue
- Last successful update: 2026/11/17
- API registrations
- Last successful update: 2026/11/17
- NMPA drug delivery notices
- Last successful update: 2026/11/17
Loaded notices dated 2026-11-03 to 2026-11-17; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.